Figure 2.

AUC values of nelfinavir, M8 and active moiety by CYP2C19 genotype following administration of normal dose of nelfinavir on day 4. CYP2C19 genotypes are denoted as follows: extensive metabolizer (*1*1), heterozygous poor metabolizer (*1*2) and homozygous poor metabolizer (*2*2). Points represent individual subject value and adjacent line indicates mean (horizontal line) and standard deviation (vertical line)